Literature DB >> 12396010

The role of ficolins in innate immunity.

Misao Matsushita1, Teizo Fujita.   

Abstract

Ficolins are a group of proteins containing both a collagen-like domain and a fibrinogen-like domain and are found in varying tissues. Ficolins present in sera have a lectin activity toward N-acetylglucosamine through their fibrinogen-like domains. The domain organizations between ficolins and mannose-binding lectin (MBL) are very similar in that both consist of a collagen-like domain and a carbohydrate-binding domain, although their carbohydrate-binding moieties are different. MBL acts as an opsonin and activates complement in association with MBL-associated serine proteases (MASPs) and sMAP, truncated protein of MASP-2, via the lectin pathway. Like MBL, two types of human serum ficolins, L-ficolin/P35 and H-ficolin, are associated with MASPs and sMAP, and activate the lectin pathway. In addition, L-ficolin/P35 acts as an opsonin. These findings indicate that serum ficolins play an important a role in innate immunity in a similar manner to MBL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12396010     DOI: 10.1078/0171-2985-00149

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  30 in total

1.  L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.

Authors:  Mioko Fujieda; Youko Aoyagi; Kousaku Matsubara; Yasuhito Takeuchi; Wakae Fujimaki; Misao Matsushita; John F Bohnsack; Shinji Takahashi
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

Review 2.  The primary role of fibrinogen-related proteins in invertebrates is defense, not coagulation.

Authors:  Patrick C Hanington; Si-Ming Zhang
Journal:  J Innate Immun       Date:  2010-11-09       Impact factor: 7.349

3.  Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

Authors:  Ole-Lars Brekke; Bernt Christian Hellerud; Dorte Christiansen; Hilde Fure; Albert Castellheim; Erik Waage Nielsen; Anne Pharo; Julie Katrine Lindstad; Grethe Bergseth; Graham Leslie; John D Lambris; Petter Brandtzaeg; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2011-08-11       Impact factor: 4.407

4.  The ancient origin of the complement system.

Authors:  Yong Zhu; Saravanan Thangamani; Bow Ho; Jeak Ling Ding
Journal:  EMBO J       Date:  2004-12-23       Impact factor: 11.598

Review 5.  Mannan-binding-lectin-associated serine proteases, characteristics and disease associations.

Authors:  Rikke Sørensen; Steffen Thiel; Jens C Jensenius
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

6.  Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease.

Authors:  I J Messias-Reason; M D Schafranski; P G Kremsner; J F J Kun
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

7.  An insight into the sialome of Glossina morsitans morsitans.

Authors:  Juliana Alves-Silva; José M C Ribeiro; Jan Van Den Abbeele; Geoffrey Attardo; Zhengrong Hao; Lee R Haines; Marcelo B Soares; Matthew Berriman; Serap Aksoy; Michael J Lehane
Journal:  BMC Genomics       Date:  2010-03-30       Impact factor: 3.969

8.  Evolution and potential function of fibrinogen-like domains across twelve Drosophila species.

Authors:  Sumit Middha; Xinguo Wang
Journal:  BMC Genomics       Date:  2008-05-30       Impact factor: 3.969

9.  Binding and agglutination of Streptococcus pneumoniae by human surfactant protein D (SP-D) vary between strains, but SP-D fails to enhance killing by neutrophils.

Authors:  Rania Jounblat; Aras Kadioglu; Francesco Iannelli; Gianni Pozzi; Paul Eggleton; Peter W Andrew
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  LPS-induced genes in intestinal tissue of the sea cucumber Holothuria glaberrima.

Authors:  Francisco Ramírez-Gómez; Pablo A Ortiz-Pineda; Gabriela Rivera-Cardona; José E García-Arrarás
Journal:  PLoS One       Date:  2009-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.